APOE and dementia: Since the model does not consider death with dementia, the higher proportion of APOE ε4-carriers among the “immortal” dementia cases in this risk population causes an apparent decrease in the sHR of death for APOE. Nevertheless, the results are still valid for estimating the incidence for APOE ε4-carriers and describe the predictive performance of the covariate.